Home » SCHERING-PLOUGH SELECTS COMPOUND FOR FURTHER DEVELOPMENT
SCHERING-PLOUGH SELECTS COMPOUND FOR FURTHER DEVELOPMENT
Schering-Plough has revealed that it is to further develop a compound for the treatment of respiratory disease identified in the company's collaboration with Pharmacopeia. Under the terms of the collaboration, the selection of the compound triggers a milestone payment to Pharmacopeia.
Pharmaceutical
Business Review
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May